Karolina Detka
Research Subjects
Karolina Detka has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Grzegorz Świercz
Collegium Medicum, Jan Kochanowski University in Kielce, 25-369 Kielce, Poland
3 shared publications - Jakub Mlodawski
Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland
3 shared publications - Marta Mlodawska
Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland
3 shared publications - Anna Zmelonek-Znamirowska
Collegium Medicum, Jan Kochanowski University in Kielce, 25-516 Kielce, Poland
2 shared publications - Agata Michalska
Collegium Medicum, Jan Kochanowski University, Kielce, Poland, Poland
1 shared publication - Anna Błażuk-Fortak
Department of Obstetrics and Gynecology, Jan Kochanowski University in Kielce, 25-369 Kielce, Poland
1 shared publication
Latest Publications
- Open Access
- 15 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8946
Predictors of Missing Outputs in AI-Based Fetal CNS Biometry Using SonoCNS: A Real-World Cohort Study
Background: Artificial intelligence (AI)-based automated fetal central nervous system (CNS) biometry using SonoCNS may streamline ultrasound assessment, but missing outputs occur in clinical practice. This study aimed to quantify the frequency and patterns of missing SonoCNS measurements across two separately acquired fetal head volumes and to investigate their associations with gestational age, operator, fetal presentation, and fetal biometric characteristics. Methods: This single-center retrospective secondary analysis used prospectively collected data from 385 women examined between 1 May 2022 and 31 May 2023. Each participant underwent second- or third-trimester ultrasound assessment with SonoCNS measurements obtained from two separately acquired volumes (a1, a2) for BPD, HC, OFD, cisterna magna (CM), lateral ventricular atrial width (Vp), and transverse cerebellar diameter (Cereb). Primary endpoints (full set: BPD/HC/OFD/CM/Vp/Cereb) were persistent AI failure (the same parameter missing in both acquisitions for at least one of the six parameters) and AI instability (missing ≥1 parameter in ≥1 acquisition). Structure-specific models assessed miss_CM, miss_Vp, and miss_Cereb. Logistic regression adjusted for operator, fetal presentation, gravidity/parity, and GA-adjusted fetal size residual z-scores (EFW-, HC-, and BPD-for-GA); sensitivity analyses were restricted to AZZ and to examinations at p < 0.001). In multivariable models, the corresponding adjusted ORs were 9.61 (95% CI 4.55–20.28), 9.62 (4.57–20.27), and 21.29 (10.25–44.22), respectively (all p < 0.001). These associations persisted in AZZ-only analyses. Examinations performed by JM were associated with lower CM/Cereb instability and persistent failure, although operator comparisons were limited by the absence of JM examinations at ≥28 weeks. Conclusions: Missing SonoCNS outputs were common across two acquisitions. Later gestational age was associated with greater output instability, particularly for lateral ventricular atrial width, but not with persistent failure after adjustment. Operator-associated differences were observed for selected endpoints; however, their interpretation is limited by the unequal gestational age distribution and the absence of objective acquisition-quality assessment.
- 15 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8946
Open AccessPredictors of Missing Outputs in AI-Based Fetal CNS Biometry Using SonoCNS: A Real-World Cohort Study
Background: Artificial intelligence (AI)-based automated fetal central nervous system (CNS) biometry using SonoCNS may streamline ultrasound assessment, but missing outputs occur in clinical practice. This study aimed to quantify the frequency and patterns of missing SonoCNS measurements across two separately acquired fetal head volumes and to investigate their associations with gestational age, operator, fetal presentation, and fetal biometric characteristics. Methods: This single-center retrospective secondary analysis used prospectively collected data from 385 women examined between 1 May 2022 and 31 May 2023. Each participant underwent second- or third-trimester ultrasound assessment with SonoCNS measurements obtained from two separately acquired volumes (a1, a2) for BPD, HC, OFD, cisterna magna (CM), lateral ventricular atrial width (Vp), and transverse cerebellar diameter (Cereb). Primary endpoints (full set: BPD/HC/OFD/CM/Vp/Cereb) were persistent AI failure (the same parameter missing in both acquisitions for at least one of the six parameters) and AI instability (missing ≥1 parameter in ≥1 acquisition). Structure-specific models assessed miss_CM, miss_Vp, and miss_Cereb. Logistic regression adjusted for operator, fetal presentation, gravidity/parity, and GA-adjusted fetal size residual z-scores (EFW-, HC-, and BPD-for-GA); sensitivity analyses were restricted to AZZ and to examinations at p < 0.001). In multivariable models, the corresponding adjusted ORs were 9.61 (95% CI 4.55–20.28), 9.62 (4.57–20.27), and 21.29 (10.25–44.22), respectively (all p < 0.001). These associations persisted in AZZ-only analyses. Examinations performed by JM were associated with lower CM/Cereb instability and persistent failure, although operator comparisons were limited by the absence of JM examinations at ≥28 weeks. Conclusions: Missing SonoCNS outputs were common across two acquisitions. Later gestational age was associated with greater output instability, particularly for lateral ventricular atrial width, but not with persistent failure after adjustment. Operator-associated differences were observed for selected endpoints; however, their interpretation is limited by the unequal gestational age distribution and the absence of objective acquisition-quality assessment.
- Open Access
- 7 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 309
Perinatal and Delivery Outcomes Following Amniocentesis: A Case-Control Study in the Polish Population
Background: Amniocentesis is a widely used invasive prenatal diagnostic procedure, recognized for its high sensitivity and low risk of complications. This study aims to evaluate the association between amniocentesis and pregnancy outcomes, such as miscarriage, preterm rupture of membranes (PROM), and preterm birth, as well as perinatal outcomes. Methods: A case-control study was conducted at the Regional Hospital in Kielce, Poland, from 2016 to 2022, involving 1834 patients, 225 of whom underwent amniocentesis, while 1609 did not receive any invasive diagnostics. Data were collected from medical records and included maternal factors such as age, BMI, delivery mode, complications, and newborn condition. Results: The study found no statistically significant differences between the study and the control groups regarding pregnancy or perinatal characteristics. Miscarriage occurred in 1.9% of the patients in the amniocentesis group, with no cases in the control group. Rates of preterm delivery were similar between groups (8.33% in the study group vs. 5.74% in the control group, p > 0.05). Postnatal outcomes, such as birth term, birth weight, and Apgar scores, were comparable across both groups. Fetal growth restriction was slightly more frequent in the study group (2.8% vs. 0.8%). One neonatal death was observed in each group. The relative risk of complications following amniocentesis was 1.69 (CI 0.38–7.24). Conclusions: Amniocentesis is a safe invasive prenatal procedure. It should be offered to every pregnant woman when necessary. Before the procedure, the patient should be clearly informed of the risk related to amniocentesis but at the same time reassured that the complication rate is very low.
- 7 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 309
Open AccessPerinatal and Delivery Outcomes Following Amniocentesis: A Case-Control Study in the Polish Population
Background: Amniocentesis is a widely used invasive prenatal diagnostic procedure, recognized for its high sensitivity and low risk of complications. This study aims to evaluate the association between amniocentesis and pregnancy outcomes, such as miscarriage, preterm rupture of membranes (PROM), and preterm birth, as well as perinatal outcomes. Methods: A case-control study was conducted at the Regional Hospital in Kielce, Poland, from 2016 to 2022, involving 1834 patients, 225 of whom underwent amniocentesis, while 1609 did not receive any invasive diagnostics. Data were collected from medical records and included maternal factors such as age, BMI, delivery mode, complications, and newborn condition. Results: The study found no statistically significant differences between the study and the control groups regarding pregnancy or perinatal characteristics. Miscarriage occurred in 1.9% of the patients in the amniocentesis group, with no cases in the control group. Rates of preterm delivery were similar between groups (8.33% in the study group vs. 5.74% in the control group, p > 0.05). Postnatal outcomes, such as birth term, birth weight, and Apgar scores, were comparable across both groups. Fetal growth restriction was slightly more frequent in the study group (2.8% vs. 0.8%). One neonatal death was observed in each group. The relative risk of complications following amniocentesis was 1.69 (CI 0.38–7.24). Conclusions: Amniocentesis is a safe invasive prenatal procedure. It should be offered to every pregnant woman when necessary. Before the procedure, the patient should be clearly informed of the risk related to amniocentesis but at the same time reassured that the complication rate is very low.
- Open Access
- 29 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1982
Navigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications
Background: Contemporary diagnostic methods aimed at assessing neonatal outcomes predominantly rely on the medical history of pregnant women. Ideally, universal biomarkers indicating an increased risk of delivering infants in poor clinical condition, with a heightened likelihood of requiring hospitalization in a Neonatal Intensive Care Unit (NICU), would be beneficial for appropriately stratifying pregnant women into a high-risk category. Our study evaluated whether biochemical and ultrasonographical markers universally used in first-trimester screenings for non-heritable chromosomal aberrations could serve this purpose. Methods: This study encompassed 1164 patients who underwent first-trimester screening, including patient history, ultrasound examinations, and biochemical tests for pregnancy-associated plasma protein-A (PAPP-A) and the free beta-HCG subunit (fbHCG), from January 2019 to December 2021. The research concentrated on the correlation between these prenatal test results and neonatal outcomes, particularly Apgar scores, umbilical blood pH levels, and the necessity for NICU admission. Results: In our cohort, neonates scoring lower than 8 on the Apgar scale at birth exhibited lower concentrations of PAPP-A in the first trimester, both in raw and normalized values (PAPP-A MoM 0.93 vs. 1.027, p = 0.032). We also observed a higher pulsatility index in the venous duct in the first trimester in full-term neonates born with p = 0.04). We also noted that neonates requiring NICU hospitalization post-delivery had lower first-trimester bHCG concentrations (0.93 MoM vs. 1.11 MoM, p = 0.03). However, none of the correlations in our study translated into a robust prognostic ability for predicting dichotomous outcomes. All areas under the curve achieved a value < 0.7. Conclusions: Low concentrations of PAPP-A and free bHCG subunit in the first trimester may be associated with poorer clinical and biochemical conditions in neonates post-delivery. However, the relationship is weak and has limited predictive capability. Further research evaluating these relationships is necessary for the appropriate stratification of pregnant women into high-risk categories for neonatological complications.
- 29 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1982
Open AccessNavigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications
Background: Contemporary diagnostic methods aimed at assessing neonatal outcomes predominantly rely on the medical history of pregnant women. Ideally, universal biomarkers indicating an increased risk of delivering infants in poor clinical condition, with a heightened likelihood of requiring hospitalization in a Neonatal Intensive Care Unit (NICU), would be beneficial for appropriately stratifying pregnant women into a high-risk category. Our study evaluated whether biochemical and ultrasonographical markers universally used in first-trimester screenings for non-heritable chromosomal aberrations could serve this purpose. Methods: This study encompassed 1164 patients who underwent first-trimester screening, including patient history, ultrasound examinations, and biochemical tests for pregnancy-associated plasma protein-A (PAPP-A) and the free beta-HCG subunit (fbHCG), from January 2019 to December 2021. The research concentrated on the correlation between these prenatal test results and neonatal outcomes, particularly Apgar scores, umbilical blood pH levels, and the necessity for NICU admission. Results: In our cohort, neonates scoring lower than 8 on the Apgar scale at birth exhibited lower concentrations of PAPP-A in the first trimester, both in raw and normalized values (PAPP-A MoM 0.93 vs. 1.027, p = 0.032). We also observed a higher pulsatility index in the venous duct in the first trimester in full-term neonates born with p = 0.04). We also noted that neonates requiring NICU hospitalization post-delivery had lower first-trimester bHCG concentrations (0.93 MoM vs. 1.11 MoM, p = 0.03). However, none of the correlations in our study translated into a robust prognostic ability for predicting dichotomous outcomes. All areas under the curve achieved a value < 0.7. Conclusions: Low concentrations of PAPP-A and free bHCG subunit in the first trimester may be associated with poorer clinical and biochemical conditions in neonates post-delivery. However, the relationship is weak and has limited predictive capability. Further research evaluating these relationships is necessary for the appropriate stratification of pregnant women into high-risk categories for neonatological complications.
- Open Access
- 5 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4492
Repeatability and Reproducibility of Potential Ultrasonographic Bishop Score Parameters
Determination of the Bishop score (BS) is a traditional method of assessing the cervix in obstetrics and gynecology. This examination is characterized by subjectivity of assessment and low repeatability. In scientific studies intended to evaluate the results of the procedure based on the initial assessment, it is necessary to find an objective scale based on ultrasonography. We selected five ultrasound parameters, measured with a transvaginal transducer, that are equivalent to the individual BS axes (dilatation assessed in three-dimensional ultrasound (DL), angle of progression (AoP), vagino-cervical angle (VCA), strain elastography using the E-Cervix module, and cervical length (CL)). All selected parameters were characterized by good to excellent repeatability (intraclass correlation coefficient (ICC) = 0.878–0.994) and reproducibility (ICC = 0.826–0.996). Each of the selected parameters significantly correlated with its corresponding BS axis. The highest value of the correlation coefficient was achieved with CL (−0.75) and DL (0.71). Other parameters were characterized by an average to high correlation (AoP and station = 0.69, hardness ratio and consistency = −0.33, position and VCA = −0.38). The best correlation with the sum of the BS points was exhibited by AoP (0.52) and CL (−0.61). The selected ultrasound parameters analogous to the BS axes were characterized by high repeatability and significant correlation with the axes of the original clinical BS. Further research into the predictive properties of a multivariate model based on these parameters is needed.
- 5 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4492
Open AccessRepeatability and Reproducibility of Potential Ultrasonographic Bishop Score Parameters
Determination of the Bishop score (BS) is a traditional method of assessing the cervix in obstetrics and gynecology. This examination is characterized by subjectivity of assessment and low repeatability. In scientific studies intended to evaluate the results of the procedure based on the initial assessment, it is necessary to find an objective scale based on ultrasonography. We selected five ultrasound parameters, measured with a transvaginal transducer, that are equivalent to the individual BS axes (dilatation assessed in three-dimensional ultrasound (DL), angle of progression (AoP), vagino-cervical angle (VCA), strain elastography using the E-Cervix module, and cervical length (CL)). All selected parameters were characterized by good to excellent repeatability (intraclass correlation coefficient (ICC) = 0.878–0.994) and reproducibility (ICC = 0.826–0.996). Each of the selected parameters significantly correlated with its corresponding BS axis. The highest value of the correlation coefficient was achieved with CL (−0.75) and DL (0.71). Other parameters were characterized by an average to high correlation (AoP and station = 0.69, hardness ratio and consistency = −0.33, position and VCA = −0.38). The best correlation with the sum of the BS points was exhibited by AoP (0.52) and CL (−0.61). The selected ultrasound parameters analogous to the BS axes were characterized by high repeatability and significant correlation with the axes of the original clinical BS. Further research into the predictive properties of a multivariate model based on these parameters is needed.